Healio

iStent inject shows long-term efficacy in variety of glaucoma cases

Implantation of a trabecular micro-bypass stent in patients with all types of glaucoma and moderate to severe glaucoma damage showed long-term efficacy and safety in a real-world, prospective, ...
Nasdaq

Glaukos’ iStent inject® Delivers Greater IOP Reduction vs. iStent® According to Newly Published Case Series

While Both iStent and iStent inject Showed Significant IOP and Medication Reduction in Combo-Cataract Procedures at 1 Year Postoperative, iStent inject Achieved Greater Absolute IOP Declines with 93% ...
Healio

iStent infinite cleared by FDA

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance for the iStent infinite trabecular micro-bypass system to reduce IOP as a stand ...
Nasdaq

Glaukos Announces FDA 510(k) Clearance of iStent infinite®

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
Reuters

Glaukos Announces Submission Of Pre-Market Approval Application For IStent Inject Trabecular Micro-Bypass

Gold prices fell on Monday to their lowest point in more than a month, as Middle East tensions pushed oil prices higher, fuelling inflation fears and reinforcing expectations of ‌higher-for-longer ...
Business Wire

Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite™

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
Business Wire

Glaukos Announces FDA 510(k) Clearance of iStent infinite ®

Novel Three-Stent Injectable System Designed to Provide Foundational, 24/7 IOP Control ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and ...